Abstract
Introduction
The notion of evidence-based medicine, first introduced by David Sackett and Brian Haynes of McMaster University in Canada, was initially used in clinical decisions or treatment guidelines [1] . However, use of the concept has been extended to overall medical healthcare and now is applied even in the area of health policy [2, 3] . The most important requirement of evidence-based medicine is to gather and integrate all medical research results to reach overall conclusions. This process is called a systematic review, and the strength of the scientific evidence or recommendations contained in each article included in the review depends on the quality of that article [4] . The concept of "levels of evidence" was introduced to quantitatively evaluate the quality of each article. The Centre for Evidence-Based Medicine (CEBM) in Oxford, England developed widely employed criteria for levels of evidence [5] . According to these guidelines, the results of each systematic review are divided into five levels based on quality. One major distinction involves homogeneous, randomized controlled trials (RCTs) versus case reports or expert opinions.
In Korea, evidence-based medicine has also been introduced to a variety of medical fields, used clinically, and adopted in education. Indeed, it is frequently used for health insurance and assessment services, which adopted evidence-based medicine as a way to evaluate the
Searching Articles and Extracting Objects for Analysis
We extracted all Korean articles published in 1996 and 2008 using the Korean medical database (KMbase) of the Medical Research Information Center (MedRIC). For non-Korean articles, we extracted all articles published in 1996 and 2008 using Medline, the US National Library of Medicine's premier bibliographic database. Because many more non-Korean than Korean articles were published, we randomly chose the same number of Korean and nonKorean articles.
Classification of Level of Evidence
We modified the widely-used 2009 criteria for evidence-based evaluation issued by the Oxford Centre for Evidence-Based Medicine (CEBM). We evaluated articles based on abstracts and then used the entire article when the abstract was not sufficient.
Data Analysis

Comparing Levels of Evidence by Nationality, Year, and Field
We classified and compared the levels of evidence in articles published in Korean versus non-Korean journals, in 1996 versus in 2008, and across different fields. We also assessed statistical significance using the chi-square test for differences in the levels of evidence in Korean versus non-Korean journals by year. We replaced the chi-square test with Fisher's exact test in cases with inappropriate sample sizes. We used SPSS software (ver. 12.0 Korean) for all analyses.
Comparing Levels of Evidence by Multiple Logistic Regression
To integrally evaluate the levels of evidence in Korean versus non-Korean articles, we divided the articles into two groups according to whether their level of evidence was high (1a, 1b, 2a, 2b) or low (3a, 3b, 4, 5). We compared the levels of evidence of these two groups using multivariate logistic analysis. Explanatory variables were nationality (Korean versus non-Korean), year, and clinical area.
Estimating Evidentiary Levels of Korean Articles
We integrated all the evidentiary levels for each journal into one score to evaluate the overall evidentiary levels of Korean articles. As the number of articles published in each clinical field differed, however, we also considered the weight of each clinical field and determine a weighted average. The weight assigned to articles in each clinical area was based on a 2007 classification of domestic articles published by Jang [7] . This study classified all medical articles published in Korea in 2007 according to medical field and analyzed the number and rate of articles in each field (Table 2) . 
Results
Comparison of Levels of Evidence by Year
1996
In 1996, more articles with high levels of evidence (1a, 1b, 2a, 3a) were published abroad, and more articles with low levels of evidence (3b and 4) were published in Korea. This difference reached statistical significance (p< 0.05; Table 3 ).
2008
In 2008, more articles with high levels of evidence (1a, 1b, 2a, 3a) were published abroad, and more articles with low levels of evidence (3b and 4) were published in Korea. Once again, this difference reached statistical significance (p < 0.05; Table 3 ).
Comparison of Levels of Evidence by Nationality
Korean Journals
No systematic reviews using data from randomized clinical trials (RCTs) were performed in 1996, and only two such reviews were performed in 2008. On the other hand, the number of reported RCTs almost doubled from 1996 to 2008, reflecting a statistically significant difference (p < 0.05). In 1996, case-control studies accounted for almost two-thirds of all articles reviewed, but this figure decreased by half in 2008, a change that reached statistical significance (p < 0.05). In 1996, two-thirds of all reports were case-control studies. However, the number of case-control studies decreased as the number of RCTs and case studies increased (Table 3) .
Non-Korean journals
Systematic reviews of RCTs accounted for only 0.27% of the total in 1996, but this figure almost quadrupled, to 1.36%, in 2008 (p < 0.05). The number of case-control studies did not significantly change, but the number of systematic reviews plus cohort studies and casecontrol studies tripled. Additionally, the number of systematic reviews of cohort studies increased by a factor of 10 (p < 0.05). However, case-control studies accounted for the largest proportion of articles in non-Korean journals in both 1996 and 2008 (Table 3) . Table 4 shows weighted averages of levels of evidence in Korean and non-Korean journals in 2008. Case-control studies accounted for the largest share, 40%, of articles in Korean journals; this was followed by case studies (35%). RCTs accounted for 5%, cohort studies accounted for less than 2.5%, and systematic reviews accounted for less than 1% of articles in Korean journals. Similarly, case-control studies accounted for the largest share of articles published in non-Korean journals, but research with higher levels of evidence were more common in non-Korean than in Korean journals. 
Table 3. Levels of Evidence in Korean and non-Korean Articles by Year
Comparison of Weighted Averages of Levels of Evidence by Nationality
Comparison of Levels of Evidence by Multiple logistic Regression
We divided articles according to level of evidence and compared the levels of evidence in Korean and non-Korean articles. Non-Korean articles had higher levels of evidence than did Korean ones, and this difference was statistically significant. Articles published in 2008 were characterized by a significantly higher level of evidence than were those published 1996. Journals in anesthesiology showed a statistically significant higher level of evidence than did other journals (Table 5 ). 
Discussion
The number of medical articles with high levels of evidence increased over the study period: the odds ratio for high levels of evidence was 1.693-fold higher in 2008 than in 1996. When the results are analyzed by nationality (Korean vs. non-Korean), however, the results changed. Even though number of RCTs doubled from 1996 to 2008 in Korean journals, large gap between Korea and oversea exist. The odds ratio for high levels of evidence was 4.181-fold higher in non-Korean journals than in Korean journals. In particular, systematic reviews have been rare in Korean journals, whereas their importance has increased outside Korea. On the other hand, case studies increased, from 27.79% in 1996 to 41.11% in 2008, indicating that the level of the evidence in Korean journals has barely improved when compared with that in non-Korean journals.
Several issues should be considered in understanding why the gap in the level of evidence in non-Korean versus Korean articles has barely changed after an interval of 10 years in which the Korean medical establishment has developed rapidly. According to Jang's statistical data on Korean medical articles published in 2007, 35.7% of articles written by Korean medical scientists were published abroad [7] . One hypothesis derived from this result is that levels of evidence in Korean and non-Korean medical articles are not, in fact, very different, but that Korean medical results are depreciated because Korean articles of high quality are actually more likely to be published in non-Korean journals. Indeed, Korean scientists tend to publish articles more frequently in overseas journals because their impact factor (in SCI) is higher than that of Korean journals. This phenomenon has been widespread in Korean academic society, including the Korean medical society, since the mid-1990s, when the performance evaluation system for university faculty based on quantitative measures of each article, especially its impact, became popular in Korea. This phenomenon is also reflected in the fact that although the number of articles in SCI journals has increased dramatically since 1997-1998, the number of articles published in Korean SCI journals remains low [8] .
Our study has several limitations. The primary problem concerns the representativeness of the journals we analyzed. An ideal result would have required analysis of all articles published in a specific year, but obvious practical difficulties interfere with review of many thousands of articles. For this reason, we selected leading journals in each clinical area, which may have resulted in the exclusion of some medical articles, especially those published in basic medicine journals. A second limitation involves the scarcity of articles with high levels of evidence. Of the 13,000 articles we studied, more than two-thirds were case studies or case-control studies, whereas we reviewed far fewer RCTs and systematic reviews. In particular, the analysis of results by field typically yielded no or only one or two articles with high levels of evidence, rendering statistical comparisons among fields meaningless.
In conclusion, we were able to detect a gap in the levels of evidence contained in medical articles published in Korea and outside Korea. However, we need to further evaluate whether this gap indicates a real difference in quality between medical articles written by Korean medical researchers and those written by foreign medical researchers or whether this gap is a function of other factors, such as the tendency for high-quality articles by Korean medical researchers to be published in non-Korean journals. This evaluation will require a search of all medical articles written by Korean scientists and published in non-Korean journals and classification of these articles as "Korean."
